SUBSCRIBE
SUBSCRIBE

Ipsen: Half-Year Statement of Ipsen’s Liquidity Contract

January 15, 2008 | 
1 min read

PARIS, France--(BUSINESS WIRE)-- Regulatory News: As of December 31, 2007, as per the liquidity contract implemented with NATIXIS SECURITIES the following assets appeared on the liquidity account :

Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
European Union flags in front of the blurred European Parliament in Brussels, Belgium
Europe
With Tariffs Looming, EU and US Pharmas Make Demands of European Commission
April 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing large scissors cutting employees in half
Layoffs
The 5 Largest Biopharma Layoffs of Q1 2025
April 10, 2025
 · 
5 min read
 · 
Angela Gabriel
Courtesy of Sarepta Therapeutics
Duchenne muscular dystrophy
Committee Recommends EU Trials of Sarepta’s Elevidys Continue, Day After Holds
April 4, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
March 28, 2025
 · 
2 min read
 · 
Dan Samorodnitsky